Discover current and future trends of Europe's life sciences industry in our comprehensive EMEA Life Sciences Industry Perspective and Cluster Report. The report examines key drivers impacting the industry and their implications for real estate markets.
The report contains enhanced cluster analysis with three distinct subsector rankings, evaluating 43 European locations based on criteria specific to:
Biopharma research and development (R&D) - highlighting clusters that excel in lab research space
Digital health & tech R&D - identifying markets requiring premium office space
Pharmaceutical manufacturing - showcasing locations ideal for warehouse and distribution assets
As the Middle East and Africa increasingly develop their life sciences capabilities, the report examines their most promising city-clusters and the opportunities they present.
Key trends
2. Rising Venture Capital flows are a testimony to Europe’s innovation capacity in the sector.
3. AI is having a dual impact; on scientific discovery and on real estate management
Through the application of Artificial Intelligence & Machine Learning in the drug discovery phase, companies can focus earlier on more promising molecules and hope to cut down the time and cost to get a drug to market.
The increasing integration of biological and computer sciences is driving demand for versatile, hybrid spaces capable of supporting both conventional lab work and data-intensive computational activities.
4. The sector’s commitment to sustainability is rapidly gaining pace
6. Life sciences clusters from Europe to the Middle East and Africa have distinctive strengths.
Want to discover our 2 new thematic benchmarks? Download the report to discover how the 43 European clusters rank for “Digital Health R&D” and “Pharmaceutical Manufacturing”.